RecruitingNCT03830229

Long Term Follow-up of Mesothelioma Patients and Their Family Members With Germline Mutations in BAP1 and Other Genes


Sponsor

National Cancer Institute (NCI)

Enrollment

1,000 participants

Start Date

Mar 13, 2019

Study Type

OBSERVATIONAL

Conditions

Summary

Background: -A gene provides instructions to the body. Mutated genes can sometimes cause cancer. Germline mutations are those people are born with. These mutations in the BAP1 gene can cause mesothelioma and other cancers. Researchers want to study people with germline mutations of BAP1 and other genes known to cause cancer. Objective: -To learn how cancer might develop in people with certain gene mutations. Eligibility: -People ages 2 and older with a germline mutation in BAP1 or another gene that might cause cancer Design: * Participants will be screened with: * Medical and family history * Saliva test * Participants with mesothelioma will be in the NIH Group. Participants without mesothelioma can choose to be in either the NIH Group or the Remote Group. * Remote Group participants will have a medical and family history by phone. If they have tumor tissue from a previous surgery, it will be tested. They will be contacted once a year by phone. * NIH Group participants will have a baseline visit. This can take up to 4 days. They may have to stay in the area overnight. The visit will include: * Physical exam * Evaluation of tumor tissue if available * Optional tumor biopsy * Blood tests * Scans: A machine will take pictures of the body. * Photographs of skin lesions or other issues * Skin exam * Eye exam * NIH Group participants will have visits once or twice a year. These will include a physical exam, lab tests, scans, and other tests as needed. * Participants who have a confirmed mutation will be asked to contact any relatives who may be at risk and ask them about joining the study.


Eligibility

Min Age: 2 Years

Plain Language Summary

Simplified for easier understanding

This study is following patients with a rare cancer called mesothelioma and their family members over the long term to better understand how certain inherited gene mutations — especially one called BAP1 — affect cancer risk and outcomes. **You may be eligible if...** - You have been diagnosed with mesothelioma AND have a known BAP1 or other DNA repair gene mutation, OR - You have mesothelioma and are being considered for genetic testing, OR - You are a close family member of someone with mesothelioma or a known BAP1 gene mutation, OR - You carry a BAP1 gene mutation even without a mesothelioma diagnosis - You are at least 2 years old **You may NOT be eligible if...** - You do not meet any of the genetic or family history criteria described above - You are unable to complete genetic counseling or testing Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

National Institutes of Health Clinical Center

Bethesda, Maryland, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT03830229


Related Trials